SELLAS Life Sciences Group, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $80.5M
Liabilities Breakdown FY2014
Total Liabilities: $43.4M
Asset Breakdown
Total Assets: $80.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $23.7M | 29.4% |
| Accounts Receivable | $1.8M | 2.3% |
| Inventory | $655.0K | 0.8% |
| Property, Plant & Equipment | $285.0K | 0.4% |
| Goodwill | $5.9M | 7.3% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $48.2M | 59.8% |
Liabilities Breakdown
Total Liabilities: $43.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.9M | 4.3% |
| Long-Term Debt | $4.5M | 10.3% |
| Other Liabilities | $37.1M | 85.3% |